Systematic review of guideline-recommended medications prescribed for treatment of low back pain

被引:20
作者
Price, Morgan R. [1 ]
Cupler, Zachary A. [2 ]
Hawk, Cheryl [3 ]
Bednarz, Edward M. [4 ]
Walters, Sheryl A. [5 ]
Daniels, Clinton J. [4 ]
机构
[1] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[2] Butler VA Hlth Care Syst, Butler, PA USA
[3] Texas Chiropract Coll, Pasadena, TX USA
[4] VA Puget Sound Hlth Care Syst, Tacoma, WA USA
[5] Logan Univ, Chesterfield, MO USA
关键词
Systematic review; Clinical practice guideline; Low back pain; Drug therapy; CLINICAL-PRACTICE GUIDELINES; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PRIMARY-CARE; SEROTONERGIC ANTIDEPRESSANTS; ORAL STEROIDS; OPIOID USE; MANAGEMENT; EFFICACY; APPRAISAL;
D O I
10.1186/s12998-022-00435-3
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective To identify and descriptively compare medication recommendations among low back pain (LBP) clinical practice guidelines (CPG). Methods We searched PubMed, Cochrane Database of Systematic Review, Index to Chiropractic Literature, AMED, CINAHL, and PEDro to identify CPGs that described the management of mechanical LBP in the prior five years. Two investigators independently screened titles and abstracts and potentially relevant full text were considered for eligibility. Four investigators independently applied the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument for critical appraisal. Data were extracted for pharmaceutical intervention, the strength of recommendation, and appropriateness for the duration of LBP. Results 316 citations were identified, 50 full-text articles were assessed, and nine guidelines with global representation met the eligibility criteria. These CPGs addressed pharmacological treatments with or without non-pharmacological treatments. All CPGS focused on the management of acute, chronic, or unspecified duration of LBP. The mean overall AGREE II score was 89.3% (SD 3.5%). The lowest domain mean score was for applicability, 80.4% (SD 5.2%), and the highest was Scope and Purpose, 94.0% (SD 2.4%). There were ten classifications of medications described in the included CPGs: acetaminophen, antibiotics, anticonvulsants, antidepressants, benzodiazepines, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, oral corticosteroids, skeletal muscle relaxants (SMRs), and atypical opioids. Conclusions Nine CPGs, included ten medication classes for the management of LBP. NSAIDs were the most frequently recommended medication for the treatment of both acute and chronic LBP as a first line pharmacological therapy. Acetaminophen and SMRs were inconsistently recommended for acute LBP. Meanwhile, with less consensus among CPGs, acetaminophen and antidepressants were proposed as second-choice therapies for chronic LBP. There was significant heterogeneity of recommendations within many medication classes, although oral corticosteroids, benzodiazepines, anticonvulsants, and antibiotics were not recommended by any CPGs for acute or chronic LBP.
引用
收藏
页数:14
相关论文
共 104 条
  • [1] AGREE Enterprise, 2014, AGREE ADV SCI PRACT
  • [2] Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy
    Albert, Hanne B.
    Sorensen, Joan S.
    Christensen, Berit Schiott
    Manniche, Claus
    [J]. EUROPEAN SPINE JOURNAL, 2013, 22 (04) : 697 - 707
  • [3] A critical appraisal of clinical practice guidelines for the treatment of lumbar spinal stenosis
    Anderson, David B.
    De Luca, Katie
    Jensen, Rikke K.
    Eyles, Jillian P.
    Van Gelder, James M.
    Friedly, Jana L.
    Maher, Christopher G.
    Ferreira, Manuela L.
    [J]. SPINE JOURNAL, 2021, 21 (03) : 455 - 464
  • [4] [Anonymous], 2019, Health Survey for England 2017: Adult Health Related Behaviours
  • [5] Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain - A preliminary concentration-controlled trial
    Atkinson, J. Hampton
    Slater, Mark A.
    Capparelli, Edmund V.
    Wallace, Mark S.
    Zisook, Sidney
    Abramson, Ian
    Matthews, Scott C.
    Garfin, Steven R.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (02) : 135 - 142
  • [6] Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity
    Atkinson, JH
    Slater, MA
    Wahlgren, DR
    Williams, RA
    Zisook, S
    Pruitt, SD
    Epping-Jordan, JE
    Patterson, TL
    Grant, I
    Abramson, I
    Garfin, SR
    [J]. PAIN, 1999, 83 (02) : 137 - 145
  • [7] A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain
    Atkinson, JH
    Slater, MA
    Williams, RA
    Zisook, S
    Patterson, TL
    Grant, I
    Wahlgren, DR
    Abramson, I
    Garfin, SR
    [J]. PAIN, 1998, 76 (03) : 287 - 296
  • [8] Lumbar Spine Injuries in Sports: Review of the Literature and Current Treatment Recommendations
    Ball, Jacob R.
    Harris, Colin B.
    Lee, Jonathan
    Vives, Michael J.
    [J]. SPORTS MEDICINE-OPEN, 2019, 5 (01)
  • [9] Revisiting Tramadol: A Multi-Modal Agent for Pain Management
    Barakat, Ahmed
    [J]. CNS DRUGS, 2019, 33 (05) : 481 - 501
  • [10] A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain
    Beaulieu, Andre D.
    Peloso, Paul
    Bensen, William
    Clark, Alexander J.
    Watson, C. Peter N.
    Gardner-Nix, Jacqueline
    Thomson, G.
    Piraino, Paula S.
    Eisenhoffer, John
    Harsanyi, Zoltan
    Darke, Andrew C.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (01) : 49 - 60